Tower Research Capital (TRC)’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $33.6K | Sell |
|
|||||
|
2025
Q2 | $42.1K | Buy |
|
|||||
|
2025
Q1 | $12.9K | Sell |
|
|||||
|
2024
Q4 | $364K | Buy |
|
|||||
|
2024
Q3 | $107K | Sell |
|
|||||
|
2024
Q2 | $225K | Buy |
|
|||||
|
2024
Q1 | $59.2K | Sell |
|
|||||
|
2023
Q4 | $328K | Buy |
|
|||||
|
2023
Q3 | $20.3K | Sell |
|
|||||
|
2023
Q2 | $79K | Buy |
|
|||||
|
2023
Q1 | $48K | Buy |
|
|||||
|
2022
Q4 | $23K | Sell |
|
|||||
|
2022
Q3 | $107K | Sell |
|
|||||
|
2022
Q2 | $100K | Buy |
|
|||||
|
2022
Q1 | $21K | Sell |
|
|||||
|
2021
Q4 | $98K | Buy |
|
|||||
|
2021
Q3 | $19K | Sell |
|
|||||
|
2021
Q2 | $43K | Buy |
|
|||||
|
2021
Q1 | $35K | Buy |
|
|||||
|
2020
Q4 | $14K | Sell |
|
|||||
|
2020
Q3 | $247K | Buy |
|
|||||
|
2020
Q2 | $13K | Buy |
|